In Ovations Holdings, Inc. is pleased to announce the implementation of the technology using sputum cytology for the early detection of lung cancer, a recognized laboratory procedure similar to the "Pap" test.
Mel Ehrlich, Ph.D. stated, "I am pleased with the diligent efforts that In Ovations Holdings, Inc. is implementing with the sputum cytology technology for the early detection of lung cancer."
INOH is on a fast track and will keep its investors and the public updated.
Lung cancer detection is presently slow, labor-intensive, expensive and not always effective until the cancer has developed which is often too late. Dr. Ehrlich’s scanning "microspectrophotometer" can detect cancer before it develops through analysis of the shape of pre-cancerous lung cells. It uses ultraviolet absorption of unstained cells which is cost effective, can be done in real time, and can have a higher confidence level of accuracy. A UV light beam produces a "raster" — an area which is scanned from side to side in lines from top to bottom. Dr. Ehrlich and his team are presently increasing the accuracy and speed of the cytology scanner for clinical laboratory use. A comprehensive evaluation of Dr. Ehrlich’s sputum cytology technology is available on the Company’s website: http://inovationsholdings.com/cytometry/.
Background: In Ovations Holdings, Inc. is pursuing several potential business opportunities. Its subsidiary, Electro Verde, Inc., markets, in conjunction with Coordinated Systems International, the patented GradiLuxtm Total Lighting System Solution which can reduce electricity consumption and carbon emissions in municipal lighting systems worldwide. The Company is also engaged in a Caribbean-based marine-related eco-tourism business and ocean search and recovery operations using state-of-the-art technology. Finally, it is a minority owner of Atmospheric Water Solutions, a company involved in water purification.